Your cart is currently empty!
Renée Arnold, PharmD
Entrepreneur-in-Residence, NIH/NHLBI & BioHealth Innovation, Inc.
President & CEO, Arnold Consultancy & Technology LLC
Renée Arnold is a global leader in Health Economics and Outcomes Research (HEOR) with 30+ years of experience guiding healthcare innovation, reimbursement strategy, and value-based decision-making. As Entrepreneur-in-Residence at NIH/NHLBI, she supports SBIR/STTR-funded teams in commercializing new technologies.
She is also the President & CEO of Arnold Consultancy & Technology LLC, where she advises on cost-effectiveness, real-world evidence, and clinical trial evaluation. A co-founder of ISPOR and an Adjunct Professor at Mount Sinai, Renée has published extensively and is a sought-after speaker on HEOR, commercialization, and healthcare innovation
Stella Wang, MPH, MS
PhD Candidate, Northwestern University Feinberg School of Medicine
Former Medical Director, Sanofi | CMO Attaché, Applied Therapeutics
Stella Wang is a healthcare leader with over 20 years of experience spanning pharmaceutical innovation, medical communications, and global health strategy. She is currently a PhD Candidate in Health Sciences at Northwestern University, focusing on medical social sciences and health measurement.
Her career includes senior roles at Sanofi, where she served as Medical Director for Sotagliflozin and Global Scientific Communications Lead for iGlarLixi, as well as leadership positions at Applied Therapeutics, driving programs in Galactosemia, SORD deficiency, and Diabetic Cardiomyopathy.